Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Future Innovation Group, 21% Increase in Ordinary Profit, Record High for The First Time in Four Years
4392 Future Innovation Group, Inc. 【J-GAAP】
Earnings ReportFuture Innovation Group, Inc. <4392> [TSE Prime] announced its financial results after the market closed on February 13th (15:35). The consolidated ordinary profit for the fiscal year ended December 2025 surged by 2.1 times that of the previous term, reaching 0.82 billion yen. For the fiscal year ending December 2026, the consolidated ordinary profit is expected to grow by 21.1% to 1.00 billion yenExpected to reach record high profits for the first time in four years.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary profit surged 2.8 times that of the same period last year, reaching 0.26 billion yen. The operating profit margin drastically improved from 1.4% in the same period last year to 8.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 13,534 | 723 | 715 | 210 | 7.0 | 5 | Feb 14, 2024 | J-GAAP |
| Dec, 2024 | 12,016 | 363 | 393 | -1,412 | -46.7 | 5 | Feb 19, 2025 | J-GAAP |
| Dec, 2025 | 13,318 | 834 | 826 | 783 | 25.8 | 10 | Feb 13, 2026 | J-GAAP |
| YoY | +10.8% | +129.8% | +110.2% | - | - |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2025 Guidance | 13,318 | 834 | 826 | 783 | 25.8 | 10 | Feb 5, 2026 | J-GAAP |
| Dec, 2025 Results | 13,318 | 834 | 826 | 783 | 25.8 | 10 | Feb 13, 2026 | J-GAAP |
| Revision Rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 6,608 | 392 | 383 | 330 | 10.9 | 0 | Aug 8, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | ー | ー | ー | ー | - | 0 | Feb 13, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2024 | 12,016 | 363 | 393 | -1,412 | -46.7 | 5 | Feb 19, 2025 | J-GAAP |
| Dec, 2025 | 13,318 | 834 | 826 | 783 | 25.8 | 10 | Feb 13, 2026 | J-GAAP |
| Dec, 2026 Guidance | 14,000 | 1,000 | 1,000 | 680 | 22.4 | 10 | Feb 13, 2026 | J-GAAP |
| YoY | +5.1% | +19.9% | +21.1% | -13.2% | -13.3% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 3,211 | 46 | 95 | -1,707 | -56.5 | 1.4 | Feb 19, 2025 | J-GAAP |
| Jan - Mar, 2025 | 3,451 | 256 | 244 | 149 | 4.9 | 7.4 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 3,157 | 136 | 139 | 181 | 6.0 | 4.3 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 3,328 | 173 | 174 | 300 | 9.9 | 5.2 | Nov 14, 2025 | J-GAAP |
| Oct - Dec, 2025 | 3,382 | 269 | 269 | 153 | 5.1 | 8.0 | Feb 13, 2026 | J-GAAP |
| YoY | +5.3% | +484.8% | +183.2% | - | - |
Related Articles
BuySell Tech, 41% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Effectively Increased
KANAME KOGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2%, Oct-Dec Ordinary Profit Increases by 1%
PARIS MIKI, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 15%, Exceeds Full-Year Plan
LUCKLAND, 3% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 20 Yen
Delta-Fly Pharma, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Widens
TAIKO PHARMA, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 8% Increase in The Current Fiscal Year, Resuming Dividends at 3.3 Yen for the First Time in five terms., This Fiscal Year to Increase Dividend by 0.2 Yen
MS&AD Insurance, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%, Exceeds Full-Year Plan
Neural Group, Last Fiscal Year's Ordinary Profit Turns to Loss, Current period performance is undisclosed.
BrightPath Biotherapeutics, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
VELTRA, 3.7 times Increase in Ordinary Profit for The Current Fiscal Year